Adeel Zubair, MD
Assistant Professor of NeurologyDownloadHi-Res Photo
Cards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileContact Info
About
Titles
Assistant Professor of Neurology
Biography
Dr. Zubair completed his undergraduate education in NY at St. John's University prior to attending Mayo Medical School in Rochester, Minnesota. Following this he completed his medicine intern year at Yale New Haven Hospital followed by a residency in Neurology. He graduated in 2020 completing a year as a chief resident in the residency program. Dr. Zubair followed his neurology training with further specialization in neuromuscular disorders. He continues to remain involved in medical education and research in a variety of neurologic disorders.
Appointments
Neurology
Assistant ProfessorPrimary
Other Departments & Organizations
- Neurology
- Neuromuscular Medicine
- Yale Medicine
Education & Training
- Neuromuscular Fellow
- Yale University, School of Medicine (2021)
- Resident
- Yale (2020)
- Chief Resident
- Yale (2020)
- Intern
- Yale New Haven Hospital (2017)
- MD
- Mayo Medical School (2016)
- BS
- St John's University, Biology (2012)
Research
Overview
Medical Research Interests
Myasthenia Gravis; Myositis; Neuromuscular Diseases; Polyneuropathies; Stroke
ORCID
0000-0002-9809-7888
Research at a Glance
Yale Co-Authors
Frequent collaborators of Adeel Zubair's published research.
Publications Timeline
A big-picture view of Adeel Zubair's research output by year.
Research Interests
Research topics Adeel Zubair is interested in exploring.
Lindsay McAlpine, MD, BSc
Bhaskar Roy, MBBS, MHS
Serena Susan Spudich, MD, MA
Adam de Havenon, MD, MSCI
Richard Nowak, MD, MS
Benison Keung, MD
51Publications
1,131Citations
Polyneuropathies
Stroke
Myasthenia Gravis
Neuromuscular Diseases
Publications
2024
Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis
Al Kasab S, Almallouhi E, Shu L, Kicielinski K, Salehi Omran S, Liebeskind D, Zubair A, Vedovati M, Paciaroni M, Antonenko K, Heldner M, de Havenon A, Henninger N, Yaghi S. Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis. Neurology Clinical Practice 2024, 15: e200381. PMID: 39399562, PMCID: PMC11464219, DOI: 10.1212/cpj.0000000000200381.Peer-Reviewed Original ResearchConceptsRisk of recurrent venous thromboembolismRecurrent venous thromboembolismCerebral venous thrombosisVenous thromboembolismFemale patientsVenous thrombosisBaseline characteristicsOutcome of cerebral venous thrombosisRate of recurrent venous thromboembolismProvoking factorsRare cause of strokeTransient provoking factorsKaplan-Meier survival analysisDuration of anticoagulationOutcomes of patientsMann-Whitney <i>Cause of strokeConsecutive patientsRare causeRecurrence rateMale patientsMulticenter studyRetrospective databaseStandard treatmentCox regressionIntravenous Thrombolysis in Patients With Cervical Artery Dissection: A Secondary Analysis of the STOP-CAD Study.
Shu L, Akpokiere F, Mandel D, Field T, Leon Guerrero C, Henninger N, Muppa J, Affan M, Haq Lodhi O, Heldner M, Antonenko K, Seiffge D, Arnold M, Salehi Omran S, Crandall R, Lester E, López-Mena D, Arauz A, Nehme A, Boulanger M, Touzé E, Sousa J, Sargento-Freitas J, Barata V, Castro-Chaves P, Brito M, Khan M, Mallick D, Rothstein A, Khazaal O, Kaufmann J, Engelter S, Traenka C, Aguiar de Sousa D, Soares M, Rosa S, Zhou L, Gandhi P, Mancini S, Metanis I, Leker R, Pan K, Dantu V, Baumgartner K, Burton T, Von Rennenberg R, Nolte C, Choi R, MacDonald J, Bavarsad Shahripour R, Guo X, Ghannam M, Almajali M, Samaniego E, Rioux B, Zine-Eddine F, Poppe A, Fonseca A, Baptista M, Cruz D, Romoli M, De Marco G, Longoni M, Keser Z, Griffin K, Kuohn L, Frontera J, Amar J, Giles J, Zedde M, Pascarella R, Grisendi I, Nzwalo H, Liebeskind D, Molaie A, Cavalier A, Kam W, Mac Grory B, Al Kasab S, Anadani M, Kicielinski K, Eltatawy A, Chervak L, Chulluncuy Rivas R, Aziz Y, Mistry E, Bakradze E, Tran T, Rodrigo-Gisbert M, Requena M, Saleh Velez F, Garcia J, Muddasani V, de Havenon A, Sanchez S, Vishnu V, Yaddanapudi S, Adams L, Browngoehl A, Ranasinghe T, Dunston R, Lynch Z, Penckofer M, Siegler J, Mayer S, Willey J, Zubair A, Cheng Y, Sharma R, Marto J, Krupka D, Klein P, Nguyen T, Asad S, Sarwat Z, Balabhadra A, Patel S, Secchi T, Martins S, Mantovani G, Kim Y, Krishnaiah B, Elangovan C, Lingam S, Qureshi A, Fridman S, Alvarado A, Khasiyev F, Linares G, Mannino M, Terruso V, Tountopoulou A, Tentolouris-Piperas V, Martinez-Marino M, Carrasco Wall V, Indraswari F, El Jamal S, Liu S, Zhou M, Alvi M, Ali F, Sarvath M, Morsi R, Kass-Hout T, Shi F, Zhang J, Sokhi D, Said J, Mongare N, Simpkins A, Gomez R, Sen S, Ghani M, Elnazeir M, Wangqin R, Xiao H, Kala N, Khan F, Stretz C, Mohammadzadeh N, Goldstein E, Furie K, Yaghi S. Intravenous Thrombolysis in Patients With Cervical Artery Dissection: A Secondary Analysis of the STOP-CAD Study. Neurology 2024, 103: e209843. PMID: 39298709, PMCID: PMC11415265, DOI: 10.1212/wnl.0000000000209843.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsAcute ischemic stroke symptomsCervical artery dissectionFunctional independenceIntravenous thrombolysisIschemic stroke symptomsStroke symptomsArtery dissectionIncidence of symptomatic intracranial hemorrhageIschemic strokeSymptomatic intracranial hemorrhageSuspected ischemic strokeClass III evidenceMedian ageSymptomatic ICHIntracranial hemorrhageSecondary analysisGuideline recommendationsICH riskIII evidenceFunctional outcomesPatientsThrombolysisCeADYoung adultsDissectionCerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study
Vedovati M, Shu L, Henninger N, Zubair A, Heldner M, Al Kasab S, Siegler J, Liebeskind D, Antonenko K, Yaghi S, Paciaroni M. Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study. Journal Of Thrombosis And Thrombolysis 2024, 57: 1008-1017. PMID: 38824485, PMCID: PMC11315801, DOI: 10.1007/s11239-024-02997-w.Peer-Reviewed Original ResearchAltmetricConceptsCases of cerebral vein thrombosisVenous thromboembolismRisk of recurrent venous thromboembolismRadiological characteristics of patientsCerebral vein thrombosisRecurrent venous thromboembolismKaplan-Meier methodLog-rank testAbsence of headacheAll-cause-deathLogistic regression analysisCharacteristics of patientsCancer statusCohort studyPropensity score matchingConsecutive patientsAssociated with cancerRadiological characteristicsVein thrombosisStudy outcomesRecanalization rateOlder ageRisk factorsMultivariate analysisPatient managementEvaluation of Neuromuscular Provider Perceptions and Office Setup for Evaluating Patients With Disabilities
Zubair A, Mikhaiel J, Keller S. Evaluation of Neuromuscular Provider Perceptions and Office Setup for Evaluating Patients With Disabilities. Journal Of Clinical Neuromuscular Disease 2024, 25: 201-202. PMID: 38771232, DOI: 10.1097/cnd.0000000000000483.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsPrevalence and Associations of Dural Arteriovenous Fistulae in Cerebral Venous Thrombosis: Analysis of ACTION-CVT
Shoskes A, Shu L, Nguyen T, Abdalkader M, Giles J, Amar J, Siegler J, Henninger N, ElNazeir M, Al Kasab S, Klein P, Heldner M, Antonenko K, Psychogios M, Liebeskind D, Field T, Liberman A, Esenwa C, Simpkins A, Li G, Frontera J, Kuohn L, Rothstein A, Khazaal O, Aziz Y, Mistry E, Khatri P, Omran S, Zubair A, Sharma R, Starke R, Morcos J, Romano J, Yaghi S, Asdaghi N. Prevalence and Associations of Dural Arteriovenous Fistulae in Cerebral Venous Thrombosis: Analysis of ACTION-CVT. Journal Of Stroke 2024, 26: 325-329. PMID: 38836280, PMCID: PMC11164588, DOI: 10.5853/jos.2023.02264.Peer-Reviewed Original ResearchCase-Control Study of Individuals With Small Fiber Neuropathy After COVID-19
McAlpine L, Zubair A, Joseph P, Spudich S. Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19. Neurology Neuroimmunology & Neuroinflammation 2024, 11: e200244. PMID: 38630952, PMCID: PMC11087026, DOI: 10.1212/nxi.0000000000200244.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInvasive cardiopulmonary exercise testingSmall fiber neuropathyCase-control studyFiber neuropathySkin biopsiesClinical response to treatmentNeurovascular dysregulationTreated with IVIGRetrospective chart reviewCase-control study of individualsRetrospective cohort studyResponse to treatmentCardiopulmonary exercise testingClass III evidenceMyalgic encephalomyelitis/chronic fatigue syndromeIVIG groupClinical responseNeuropathic symptomsChart reviewIVIGStudy of individualsCohort studyIII evidenceClinical trialsCOVID-19 illnessComparative analysis of energy expenditure and costs in neuroimaging
Signorile W, Mahajan A, Fulbright R, Zubair A. Comparative analysis of energy expenditure and costs in neuroimaging. Journal Of The Neurological Sciences 2024, 460: 123001. PMID: 38616465, DOI: 10.1016/j.jns.2024.123001.Peer-Reviewed Original ResearchMeSH KeywordsExternal validation of the SI2NCAL2C score for outcomes following cerebral venous thrombosis
Klein P, Shu L, Lindgren E, de Winter M, Siegler J, Simpkins A, Omran S, Heldner M, de Havenon A, Abdalkader M, Al Kasab S, Stretz C, Wu T, Wilson D, Asad S, Almallouhi E, Frontera J, Kuohn L, Rothstein A, Bakradze E, Henninger N, Zubair A, Sharma R, Kerrigan D, Aziz Y, Mistry E, van Kammen M, Tatlisumak T, Krzywicka K, Aguiar de Sousa D, Jood K, Field T, Yaghi S, Coutinho J, Nguyen T. External validation of the SI2NCAL2C score for outcomes following cerebral venous thrombosis. Journal Of Stroke And Cerebrovascular Diseases 2024, 33: 107720. PMID: 38614162, DOI: 10.1016/j.jstrokecerebrovasdis.2024.107720.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsCerebral venous thrombosisArea under the receiver operating characteristic curvePoor outcomeVenous thrombosisCentral nervous system infectionInternational retrospective studyNervous system infectionExternal validation cohortFocal neurological deficitsReceiver operating characteristic curvePoor outcome dataLevels of hemoglobinLack of follow-upPoorer outcome scoresConsecutive patientsClinical presentationRetrospective studyValidation cohortIntracerebral hemorrhageNeurological deficitsFollow-upOutcome scoresSystemic infectionLevels of glucoseInternational cohortUtilization of wearable technology to track functional changes in a patient with myopathy
Zubair A. Utilization of wearable technology to track functional changes in a patient with myopathy. Brain Circulation 2024, 10: 190-191. PMID: 39036302, PMCID: PMC11259317, DOI: 10.4103/bc.bc_104_23.Peer-Reviewed Original ResearchHTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations
Saab L, DiCapua D, Zubair A. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations. Journal Of The Neurological Sciences 2024, 459: 122973. PMID: 38520941, DOI: 10.1016/j.jns.2024.122973.Peer-Reviewed Original ResearchAltmetricConceptsHTLV-1-associated myelopathy/tropical spastic paraparesisMyelopathy/tropical spastic paraparesisHTLV-1Discussion of risk factorsInfected CD4+ T cellsCD4+ T cellsAdult T-cell leukemia/lymphomaSpastic paraparesisT-cell leukemia/lymphomaQuality of lifeOptimal patient outcomesHTLV-1 infectionSymptoms of weaknessManaging symptomsDuration of infectionLoss of bladder controlNonspecific symptomsT cellsLower extremitiesSensory disturbancePatient outcomesTherapeutic considerationsHAM/TSPProviral loadRisk factors
Clinical Trials
Current Trials
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
HIC ID2000031893RoleSub InvestigatorPrimary Completion Date03/07/2028Recruiting ParticipantsGenderBothAge30 years - 80 years
Academic Achievements & Community Involvement
honor Gilbert Glaser Award
Yale School of Medicine AwardYale University, School of Medicine, Department of NeurologyDetails06/12/2019United States
Clinical Care
Overview
Adeel Zubair, MD, is a neurologist with a specialization in neuromuscular medicine. He cares for patients with memory disorders, migraines, muscle disorders, and those who have had abnormal neuroimaging. “I enjoy interacting with my patients and crafting a plan that works to help diagnose and treat their concerns,” he says.
Dr. Zubair decided to work in neurology because he wanted to be part of field that involved constant learning, and where he could help people. “The neurologic examination can help localize problems and is an integral part of the neurologist's toolbox. Talking and getting to know patients allows me to understand them as a whole, allowing us to work together to make an appropriate diagnostic and therapeutic plan," he says.
An assistant professor of neurology at Yale School of Medicine (YSM), Dr. Zubair is involved in medical education at YSM and has clinical research interests in a variety of neurologic disorders. He also participated in a neurology rotation at Makerere University in Uganda through the Yale/Stanford J& Global Health Scholars Program.
Clinical Specialties
Neuromuscular Medicine
Fact Sheets
Neuropathy
Learn More on Yale MedicinePeripheral Neuropathy
Learn More on Yale MedicineDizziness
Learn More on Yale MedicineCarotid Artery Disease Imaging
Learn More on Yale Medicine
Board Certifications
Neuromuscular Medicine (Neurology)
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2022
Neurology
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2020
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
Get In Touch
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.